Nasdaq · Healthcare
Lantheus Holdings, Inc. (LNTH)
As-reported financials and recent SEC filings for Lantheus Holdings, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.54B
Net income
$233.6M
Net margin
15.2%
Diluted EPS
$3.41
ROE
21.4%
P/E (TTM)
26.2×
Market cap
$7.15B
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.54B | $1.53B | $1.30B | $935.1M | $425.2M |
| Gross profit | $942.0M | $988.3M | $709.5M | $581.7M | $187.7M |
| Operating income | $310.8M | $457.0M | $364.6M | $36.2M | $-60.8M |
| Net income | $233.6M | $312.4M | $326.7M | $28.1M | $-71.3M |
| Diluted EPS | $3.41 | $4.36 | $4.65 | $0.40 | $-1.06 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →SD2026-05-29
View on EDGAR →42026-05-18
View on EDGAR →42026-05-18
View on EDGAR →42026-05-18
View on EDGAR →42026-05-18
View on EDGAR →42026-05-18
View on EDGAR →Go deeper on LNTH
Search Lantheus Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.